Comparison

Combretastatin A4 (CA-4; CRC 87-09)

Item no. V1610-500mg
Manufacturer InvivoChem LLC
CASRN 117048-59-6
Amount 500 mg
Quantity options 100 mg 10 mg 1 g 250 mg 25 mg 50 mg 5 mg
Category
Type Biochemicals
Specific against other
ECLASS 10.1 32160490
ECLASS 11.0 32160490
UNSPSC 12000000
Available
Description
InvivoChem Cat #:V1610CAS #:117048-59-6Purity >=98%

Description: Combretastatin A4 (CA-4; CRC-87-09) is a highly potent tubulin inhibitor with potential antitumor activity. It belongs to the so called microtubule-targeting agent (MTA) or microtubule disrupting agent and acts by binding to beta-tubulin with a Kd of 0.4 uM.

References: J Med Chem. 2014 Apr 24; 57(8):3369-81; Magn Reson Med. 2016 Feb; 75(2):866-72.

Publications Citing Use of InvivoChem Combretastatin A4 (CA-4; CRC 87-09):

1) Eur J Med Chem. 2019 Dec 15; 184:111732. doi: 10.1016/j.ejmech.2019.111732;

2) Eur J Med Chem. 2021 Mar 5; 213:113058. doi: 10.1016/j.ejmech.2020.113058.

Molecular Weight (MW)
316.35
Formula
C18H20O5
CAS No.
117048-59-6
Storage
-20C for 3 years in powder form
-80C for 2 years in solvent
Solubility (In vitro)
DMSO: 63 mg/mL (199.1 mM)
Water:< 1 mg/mL
Ethanol: 34 mg/mL (107.5 mM)
Solubility (In vivo)
5% DMSO+50% PEG 300+ddH2O: 30mg/mL
Synonyms
Combretastatin A-4; Combretastatin A 4; Combretastatin A4; CRC 87-09; CRC 87-09; CRC 87-09; CA-4; CA4; CA 4;

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 500 mg
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close